Skip to main content
Top

Inflammation Research

Issue 12/2013

Content (8 Articles)

Original Research Paper

Docosahexaenoic acid reduces inflammation and joint destruction in mice with collagen-induced arthritis

Melissa V. Olson, Ying-Chun Liu, Bindi Dangi, J. Paul Zimmer, Norman Salem Jr., Julie M. Nauroth

Open Access Original Research Paper

The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers

Maciej Chalubinski, Katarzyna Zemanek, Wojciech Skowron, Katarzyna Wojdan, Paulina Gorzelak, Marlena Broncel

Original Research Paper

Inflammatory mediators of systemic inflammation in neonatal sepsis

V. Sugitharini, A. Prema, E. Berla Thangam

Original Research Paper

Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines

Chun Wang, Jun Yuan, Hua-xun Wu, Yan Chang, Qing-tong Wang, Yu-jing Wu, Li-hua Liu, Wei Wei

Open Access Original Research Paper

Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators

Bertold Renner, Gabi Ahne, Elke Grosan, Birgit Kettenmann, Gerd Kobal, Adrian Shephard

Original Research Paper

Effects of four antitussives on airway neurogenic inflammation in a guinea pig model of chronic cough induced by cigarette smoke exposure

Yu-long Luo, Pei-bo Li, Chen-chen Zhang, Yan-fang Zheng, Sheng Wang, Yi-chu Nie, Ke-jian Zhang, Wei-wei Su

Original Research Paper

Serum amyloid A, phospholipase A2-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases

Mario Menschikowski, Albert Hagelgans, Susanne Fuessel, Olga A. Mareninova, Liana Asatryan, Manfred P. Wirth, Gabriele Siegert

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine